These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25651258)

  • 21. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

  • 22. New drug combination may shorten tuberculosis treatment, study says.
    Mayor S
    BMJ; 2015 Mar; 350():h1518. PubMed ID: 25788408
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy].
    Khomenko AG; Fadeeva NI; Golyshevskaia VI
    Probl Tuberk; 1983 Jul; (7):48-54. PubMed ID: 6415652
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 25. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of molecular-biological microchip TB-BIOCHIP-2 for detecting of Mycobacterium tuberculosis with multidrug resistance to fluoroquinolones in patients with new detected and chronic tuberculosis].
    Nosova EIu; Galkina KIu; Antonova OV; Garmash IuIu; Skotnikova OI; Moroz AM
    Vestn Ross Akad Med Nauk; 2008; (3):16-9. PubMed ID: 18421904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis].
    Sokolova GB; Khaĭmenova TIa; Borisov SE; Lazareva IaV; Bogadel'nikova IV; Biron MG; Mozhokina GN; Tsibanev AA
    Probl Tuberk Bolezn Legk; 2007; (6):40-5. PubMed ID: 17674470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
    Burman WJ; Goldberg S; Johnson JL; Muzanye G; Engle M; Mosher AW; Choudhri S; Daley CL; Munsiff SS; Zhao Z; Vernon A; Chaisson RE
    Am J Respir Crit Care Med; 2006 Aug; 174(3):331-8. PubMed ID: 16675781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New tuberculosis therapy offers potential shorter treatment.
    Wkly Epidemiol Rec; 2006 Jan; 81(2):19-20. PubMed ID: 16671244
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mycobacterium tuberculosis L forms in patients with pulmonary and pleural tuberculosis during antibacterial chemotherapy].
    Osiĭskiĭ IIu; Kotliar KD
    Vrach Delo; 1989 Sep; (9):55-6. PubMed ID: 2514488
    [No Abstract]   [Full Text] [Related]  

  • 31. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antituberculosis drug resistance pattern among newly diagnosed pulmonary tuberculosis patients in south west Nigeria.
    Daniel O; Osman E; Awe A; Ogiri S; Lawal W; Sobaloju S
    Ann Afr Med; 2011; 10(3):256-7. PubMed ID: 21912015
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.
    Lee BY; Clemens DL; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
    Nat Commun; 2017 Jan; 8():14183. PubMed ID: 28117835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand].
    Azaev MSh; Agafonov AP; Bodnev SA; Blinov VM
    Antibiot Khimioter; 2006; 51(11-12):7-10. PubMed ID: 18318141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of treatment of chronic pulmonary tuberculosis Mycobacterium in the sputum].
    Petrović B; Radović R; Petrović O; Arsenijević N; Jevdjić P; Jordanov S
    Tuberkuloza; 1967; 19(5):658-60. PubMed ID: 4971786
    [No Abstract]   [Full Text] [Related]  

  • 36. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 37. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of antibacterial treatment of patients with bacteriologically confirmed pulmonary tuberculosis in Poland 1982].
    Szczuka I
    Pneumonol Pol; 1984 Sep; 52(9):409-18. PubMed ID: 6442409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.